, Volume 8, Supplement 1, pp S139–S154 | Cite as

Effect of piroxicam on structure and function of joint cartilage

  • W. Mohr
  • C. J. Kirkpatrick
  • A. Wildfeuer
  • M. Leitold
Effects of Non-steroidal Anti-inflammatory Drugs on Immunity, Inflammation and Disease Focus on Piroxicam


In vitro experiments were performed on isolated articular chondrocytes under the influence of piroxicam. It was demonstrated that this non-steroidal anti-inflammatory agent affected neither cell proliferation nor the incorporation of35SO4 into matrix macromolecules. Dogs were treated with piroxicam for 8 weeks. Morphological studies were performed on the tissues of the knee joints. Macroscopic and light microscopic investigations revealed no structural differences between the tissues (synovial membrane and articular cartilage) of control and treated dogs. Even at the ultrastructural level no alterations in the cartilage were observed. The capacity of chondrocytes to incorporate35SO4 under in vitro conditions was identical in control and experimental animals. It is concluded that piroxicam has no adverse effect on chondrocytes under in vitro conditions or on articular cartilage structure in the in vivo model.


Adverse Effect Cell Proliferation Experimental Animal Macromolecule Articular Cartilage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kalbhen, D. A. 1982. Arthrosis deformans. Experimentell-pharmakologische Studien und ihre klinische Bedeutung. Eular, Basel.Google Scholar
  2. 2.
    Kirkpatrick, C. J., W. Mohr, andO. Haferkamp. 1982. Alterations in chondrocyte morphology, proliferation and binding of35SO4 due to Fe(III), Fe(II), ferritin and haemoglobin in vitro.Virchows Arch. Cell Pathol. 38:297–306.Google Scholar
  3. 3.
    Kirkpatrick, C. J., W. Mohr, andO. Haferkamp. 1982. The effects of nickel ions on articular chondrocyte growth in monolayer culture.Res. Exp. Med. 181:259–264.Google Scholar
  4. 4.
    Kiskpatrick, C. J., W. Mohr, andO. Haferkamp. 1982. Alterations in articular chondrocyte growth and proteoglycan synthesis due to prostanoid precursors.Rheumatot. Int. 2:31–34.Google Scholar
  5. 5.
    Green, W. T., Jr. 1971. Behaviour of articular chondrocytes in cell culture.Clin. Orthop. 75: 248–260.Google Scholar
  6. 6.
    Sokoloff, L., C. J. Malemud, andW. T. Green Jr. 1970. Sulfate incorporation by articular chondrocytes in monolayer culture.Arthritis Rheum. 13:118–124.Google Scholar
  7. 7.
    Fratantoni, J. C., C. W. Hall, andE. F. Neufeld. 1968. The defect in Hurler's and Hunter's syndromes: faulty degradation of mucppolysaccharide.Proc. Natl. Acad. Sci. USA 60:699–706.Google Scholar
  8. 8.
    Corvol, M.-T., C. J. Malemud, andL. Sokoloff. 1972. A pituitary growth-promoting factor for articular chondrocytes in monolayer culture.Endocrinology 90:262–271.Google Scholar
  9. 9.
    Burton, K. 1956. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.J. Biochem. 62:315–323.Google Scholar
  10. 10.
    Stockwell, R. A. 1979. Biology of Cartilage Cells. Cambridge University Press. London.Google Scholar
  11. 11.
    Wiseman, E. H., andJ. A. Boyle. 1980. Piroxicam (Feldene).Clin. Rheum. Dis. 6:585–613.Google Scholar
  12. 12.
    Twomey, T. M., S. R. Bartollucci, andD. C. Hobbs. 1980. Analysis of piroxicam in plasma by high-performance liquid-chromatography.J. Chromatogr. 183:104–108.Google Scholar
  13. 13.
    Rosenberg, L. 1971. Chemical basis for the histological use of safranin-0 in the study of articular cartilage.J. Bone Joint Surg. 53A:69–82.Google Scholar
  14. 14.
    Lust, G., andB. A. Summers. 1981. Early, asymptomatic stage of degenerative joint disease in canine hip joints.Am. J. Vet. Res. 42:1849–1855.Google Scholar
  15. 15.
    Palmoski, M. J., R. A. Colyer, andK. D. Brandt. 1980. Joint motion in the absence of normal loading does not maintain normal articular cartilage.Arthritis Rheum. 23:325–334.Google Scholar
  16. 16.
    Ghadially, F. N. 1981. Structure and function of articular cartilage.Clin. Rheum. Dis. 7:3–28.Google Scholar
  17. 17.
    Aspden, R. M., andD. W. L. Hukins. 1979. The lamina splendens of articular cartilage is an artefact of phase contrast microscopy.Proc. R. Soc. London B 206:109–113.Google Scholar
  18. 18.
    Weiss, C. 1973. Ultrastructural characteristics of osteoarthritis.Fed. Proc. 32:1459–1466.Google Scholar
  19. 19.
    Silberberg, M., R. Silberberg, andM. Hasler. 1966. Fine structure of articular cartilage in mice receiving cortisone acetate.Arch. Pathol. 82:569–582.Google Scholar
  20. 20.
    Carrabba, M., B. Colombo, E. Gavoni, andG. Cenacchi. 1982. Ultrastructural approach to the understanding of osteoarthrosis.Rheumatology 7:53–63.Google Scholar
  21. 21.
    Stockwell, R. 1982. Animal models of degenerative joint disease.In Bone and Joint Disease. C. L. Berry, editor. Springer, Berlin;Current Topics in Pathology 71:265–297.Google Scholar
  22. 22.
    Wiltberger, H., andG. Lust. 1975. Ultrastructure of canine articular cartilage: comparison of normal and degenerative (osteoarthritic) hip joints.Am. J. Vet. Res. 36:727–740.Google Scholar
  23. 23.
    Roy, S. 1970. Ultrastructure of articular cartilage in experimental immobilisation,Ann. Rheum. Dis. 29:634–642.Google Scholar
  24. 24.
    Finsterbush, A., andB. Friedman. 1973. Early changes in immobilized rabbits' knee joints A light and electron microscopic study.Clin. Orthop. 92:305–319.Google Scholar
  25. 25.
    Watson, M. 1976. The suppressing effect of indomethacin on articular cartilage.Rheumatol. Rehabil. 15:26–30.Google Scholar
  26. 26.
    Lust, G., W. Pronsky, andD. M. Sherman. 1972. Biochemical and ultrastructural observations in normal and degenerative canine articular cartilage.Am. J. Vet. Res. 33:2429–2440.Google Scholar
  27. 27.
    Miller, D. R., andG. LusT. 1979. Accumulation of procollagen in the degenerative articular cartilage of dogs with osteoarthritis.Biochem. Biophys. Acta 538:218–231.Google Scholar
  28. 28.
    Chrisman, O. D., I. M. Ladenbauer-Bellis, andJ. P. Fulkerson. 1981. The osteoarthritic cascade and associated drug actions.Semin. Arthritis Rheum. 11:145.Google Scholar
  29. 29.
    Wiseman, E. H. 1978. Review of preclinical studies with piroxicam: pharmacology, pharmacokinetics and toxicology.In Piroxicam. Proceedings of a symposium held during the 14th International Congress of Rheumatology, San Francisco, 30 June 1977. Royal Society of Medicine International Congress and Symposium Series, No. 1. Royal Society of Medicine, London; Grune and Stratton, New York. 11–23.Google Scholar
  30. 30.
    Kirkpatrick, C. J., W. Mohr, A. Wildfeuer, andO. Haferkamp. 1983. Influence of non-steroidal anti-inflammatory agents on lapine articular chondrocyte growth in vitro.Z. Rheumatol. 42:58–65.Google Scholar
  31. 31.
    Mohr, W., C. J. Kirkpatrick, A. Wildfeuer, andM. Leitold. 1983. Der Einfluss von Piroxicam auf Struktur und Funktionen des Gelenkknorpels.Z. Rheumatol. 42:70–77.Google Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • W. Mohr
    • 1
  • C. J. Kirkpatrick
    • 1
  • A. Wildfeuer
    • 2
  • M. Leitold
    • 2
  1. 1.Department of PathologyUniversity of UtmUlmWest Germany
  2. 2.Department for Research and DevelopmentHeinrich Mack Nachf.IllertissenGermany

Personalised recommendations